ClinicalTrialsFinder
RecruitingPhase 1Phase 2NCT05774704

Curcumin and Retinal Study

Curcumin and Retinal Amyloid-beta Pilot Study

Sponsor

Texas Tech University Health Sciences Center

Enrollment

60 participants

Start Date

Aug 21, 2023

Study Type

INTERVENTIONAL

Conditions

SafetyGut MicrobiomeBioavailability

Summary

To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.

Eligibility

Min Age: 40 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called High curcumin group and a drug called Low curcumin group for people with bioavailability, gut microbiome, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLow curcumin group

One curcumin capsule (250 mg curcumin) after each meal, 3 times a day for 2 weeks.

DRUGHigh curcumin group

One curcumin capsule (500 mg curcumin) after each meal, 3 times a day for 2 weeks.

Locations(1)

Texas Tech University Health Sciences Center

Lubbock, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05774704

Related Trials

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

NCT073655141 location

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

NCT067336751 location

The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study

NCT050902671 location

Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

NCT064333101 location

Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach

NCT053348881 location